Prices as of 2025-11-24 16:15:34 ET
Ticker Appearances
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - May 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Technical Strategy
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Daily Technical Strategy
Emerging markets could bounce into End-of-Yr. as DXY decline continues
EQUITY TRENDS FROM AUGUST REMAIN BULLISH, AND SPX HAS NEARED THE UPPER EDGE OF ITS FOUR-MONTH CHANNEL RESISTANCE WHILE THE NASDAQ 100 INDEX HAS JUST...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Daily Technical Strategy
Healthcare on the verge of breaking out to new All-time highs on an Equal-weighted basis
THE RECENT STALLING OUT IN MOST US EQUITY INDICES OVER THE LAST WEEK HASN’T TAKEN AWAY FROM THE APPEAL OF THE CURRENT RALLY FROM EARLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - May 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Technical Strategy
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Daily Technical Strategy
Emerging markets could bounce into End-of-Yr. as DXY decline continues
EQUITY TRENDS FROM AUGUST REMAIN BULLISH, AND SPX HAS NEARED THE UPPER EDGE OF ITS FOUR-MONTH CHANNEL RESISTANCE WHILE THE NASDAQ 100 INDEX HAS JUST...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Daily Technical Strategy
Healthcare on the verge of breaking out to new All-time highs on an Equal-weighted basis
THE RECENT STALLING OUT IN MOST US EQUITY INDICES OVER THE LAST WEEK HASN’T TAKEN AWAY FROM THE APPEAL OF THE CURRENT RALLY FROM EARLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - May 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Technical Strategy
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Daily Technical Strategy
Emerging markets could bounce into End-of-Yr. as DXY decline continues
EQUITY TRENDS FROM AUGUST REMAIN BULLISH, AND SPX HAS NEARED THE UPPER EDGE OF ITS FOUR-MONTH CHANNEL RESISTANCE WHILE THE NASDAQ 100 INDEX HAS JUST...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Daily Technical Strategy
Healthcare on the verge of breaking out to new All-time highs on an Equal-weighted basis
THE RECENT STALLING OUT IN MOST US EQUITY INDICES OVER THE LAST WEEK HASN’T TAKEN AWAY FROM THE APPEAL OF THE CURRENT RALLY FROM EARLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: d682ee-7ce8b6-67145d-f85a3f-f460c2 Array ( [cookie] => d682ee-7ce8b6-67145d-f85a3f-f460c2 [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.41 )
Articles Read 2/2
🎁 Unlock 1 extra article by joining our Community!
You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.
Already have an account? Sign In d682ee-7ce8b6-67145d-f85a3f-f460c2
Already have an account? Sign In d682ee-7ce8b6-67145d-f85a3f-f460c2
